Published in PLoS One on April 16, 2013
Examining the safety of respiratory and intravenous inoculation of Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus in a mouse model. Sci Rep (2015) 0.93
Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Front Microbiol (2016) 0.90
Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates. Front Microbiol (2014) 0.89
Dysbiotic events in gut microbiota: impact on human health. Nutrients (2014) 0.87
Predatory prokaryotes wage war against eye infections. Future Microbiol (2014) 0.84
Bdellovibrio and like organisms enhanced growth and survival of Penaeus monodon and altered bacterial community structures in its rearing water. Appl Environ Microbiol (2014) 0.80
Cell-cycle progress in obligate predatory bacteria is dependent upon sequential sensing of prey recognition and prey quality cues. Proc Natl Acad Sci U S A (2015) 0.79
Visualizing Bdellovibrio bacteriovorus by Using the tdTomato Fluorescent Protein. Appl Environ Microbiol (2015) 0.79
Shedding light on microbial predator-prey population dynamics using a quantitative bioluminescence assay. Microb Ecol (2013) 0.78
Spatially Organized Films from Bdellovibrio bacteriovorus Prey Lysates. Appl Environ Microbiol (2014) 0.77
Injections of Predatory Bacteria Work Alongside Host Immune Cells to Treat Shigella Infection in Zebrafish Larvae. Curr Biol (2016) 0.77
Dysbiosis a risk factor for celiac disease. Med Microbiol Immunol (2017) 0.76
Engineering a predatory bacterium as a proficient killer agent for intracellular bio-products recovery: The case of the polyhydroxyalkanoates. Sci Rep (2016) 0.76
Predatory bacteria are nontoxic to the rabbit ocular surface. Sci Rep (2016) 0.76
Susceptibility of Select Agents to Predation by Predatory Bacteria. Microorganisms (2015) 0.75
Isolation of Bdellovibrio sp. from soil samples in Mexico and their potential applications in control of pathogens. Microbiologyopen (2016) 0.75
Effect of predatory bacteria on the gut bacterial microbiota in rats. Sci Rep (2017) 0.75
Investigating the Responses of Human Epithelial Cells to Predatory Bacteria. Sci Rep (2016) 0.75
BspK, a serine protease from the predatory bacterium Bdellovibrio bacteriovorus with utility for analyzing therapeutic antibodies. Appl Environ Microbiol (2016) 0.75
Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period. MBio (2017) 0.75
The Underlying Ecological Processes of Gut Microbiota Among Cohabitating Retarded, Overgrown and Normal Shrimps. Microb Ecol (2016) 0.75
A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem (2009) 40.90
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell (2006) 18.83
BDELLOVIBRIO BACTERIOVORUS GEN. ET SP. N., A PREDATORY, ECTOPARASITIC, AND BACTERIOLYTIC MICROORGANISM. Antonie Van Leeuwenhoek (1963) 8.81
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis (2001) 4.17
A predator unmasked: life cycle of Bdellovibrio bacteriovorus from a genomic perspective. Science (2004) 3.87
Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One (2010) 3.38
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11
Factors affecting the intracellular parasitic growth of Bdellovibrio bacteriovorus developing within Escherichia coli. J Bacteriol (1969) 2.99
Defined spatial structure stabilizes a synthetic multispecies bacterial community. Proc Natl Acad Sci U S A (2008) 2.42
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut (2006) 2.24
Studies of intestinal lymphoid tissue. III. Quantitative analyses of epithelial lymphocytes in the small intestine of human control subjects and of patients with celiac sprue. Gastroenterology (1980) 2.22
The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol (2010) 2.22
Structure of the flagellum of Bdellovibrio bacteriovorus. J Bacteriol (1968) 2.21
Distantly sampled soils carry few species in common. ISME J (2008) 2.00
Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut (2006) 1.81
Host-bacterial symbiosis in health and disease. Adv Immunol (2010) 1.73
How do Swedish paediatric clinics diagnose coeliac disease? Results of a nationwide questionnaire study. Acta Paediatr (2006) 1.67
Characterizing the flagellar filament and the role of motility in bacterial prey-penetration by Bdellovibrio bacteriovorus. Mol Microbiol (2006) 1.60
Susceptibility of biofilms to Bdellovibrio bacteriovorus attack. Appl Environ Microbiol (2005) 1.55
Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol (2011) 1.46
Identification of a Bdellovibrio bacteriovorus genetic locus, hit, associated with the host-independent phenotype. J Bacteriol (1992) 1.37
Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota. Inflamm Bowel Dis (2007) 1.34
Microbiota in pediatric inflammatory bowel disease. J Pediatr (2010) 1.34
Prey range characterization, ribotyping, and diversity of soil and rhizosphere Bdellovibrio spp. isolated on phytopathogenic bacteria. Appl Environ Microbiol (2000) 1.28
Bacterial predator-prey interaction at low prey density. Appl Environ Microbiol (1978) 1.27
The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. BMB Rep (2012) 1.26
Structure analysis of a soil community of predatory bacteria using culture-dependent and culture-independent methods reveals a hitherto undetected diversity of Bdellovibrio-and-like organisms. Environ Microbiol (2006) 1.24
Effects of orally administered Bdellovibrio bacteriovorus on the well-being and Salmonella colonization of young chicks. Appl Environ Microbiol (2011) 1.23
Use of gDNA as internal standard for gene expression in staphylococci in vitro and in vivo. Biochem Biophys Res Commun (2002) 1.21
Bdellovibrio as symbiont; the associations of Bdellovibrios with other bacteria interpreted in terms of a generalized scheme for classifying organismic associations. Symp Soc Exp Biol (1975) 1.17
A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol (2010) 1.14
Differential predation by Bdellovibrio bacteriovorus 109J. Curr Microbiol (2006) 1.08
Plastic phenotypic resistance to predation by Bdellovibrio and like organisms in bacterial prey. Environ Microbiol (2004) 1.05
Sharing of prey: coinfection of a bacterium by a virus and a prokaryotic predator. MBio (2012) 1.05
Microbial biofilm communities in the gastrointestinal tract. J Clin Gastroenterol (2008) 1.04
Taxonomic studies of predatory bdellovibrios based on 16S rRNA analysis, ribotyping and the hit locus and characterization of isolates from the gut of animals. Syst Appl Microbiol (2001) 1.04
Bdellovibrio and the intestinal flora of vertebrates. Appl Environ Microbiol (1977) 1.04
Relationship of Bdellovibrio elongation and fission to host cell size. J Bacteriol (1976) 0.99
Mucosal biofilm communities in the human intestinal tract. Adv Appl Microbiol (2011) 0.96
Predatory Bdellovibrio bacteria use gliding motility to scout for prey on surfaces. J Bacteriol (2011) 0.96
Predatory mechanisms of Bdellovibrio and like organisms. Future Microbiol (2007) 0.94
Unbalanced growth as a normal feature of development of Bdellovibrio bacteriovorus. Arch Microbiol (1989) 0.92
Retracted Gut microbiota and pediatric disease. Dig Dis (2011) 0.92
Bdellovibrio predation in the presence of decoys: Three-way bacterial interactions revealed by mathematical and experimental analyses. Appl Environ Microbiol (2006) 0.91
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun (2012) 0.90
Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.89
Isolation of Bdellovibrio as biological therapeutic agents used for the treatment of Aeromonas hydrophila infection in fish. Zoonoses Public Health (2009) 0.84
Molecular typing and identification of Bdellovibrio-and-like organisms isolated from seawater shrimp ponds and adjacent coastal waters. J Appl Microbiol (2009) 0.84
Development and performance of a quantitative PCR for the enumeration of Bdellovibrionaceae. Environ Microbiol Rep (2009) 0.84
The incidence of Bdellovibrio spp. in man-made water systems: coexistence with legionellas. J Appl Bacteriol (1990) 0.78
[Isolation and characterization of Bdellovibrio strains from the ocean]. Wei Sheng Wu Xue Bao (2008) 0.76
Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet (2009) 3.82
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet (2008) 3.36
Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol (2006) 2.24
ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr (2014) 1.78
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol (2010) 1.74
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr (2012) 1.52
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Small intestine contrast ultrasonography in pediatric Crohn's disease. J Pediatr (2013) 1.49
A child with aphthae and diarrhoea. Lancet (2002) 1.45
Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network. J Pediatr Gastroenterol Nutr (2016) 1.39
Inhibition of influenza A virus replication by resveratrol. J Infect Dis (2005) 1.33
Inflammation is the main determinant of low bone mineral density in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2007) 1.23
Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN. Am J Gastroenterol (2011) 1.16
A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol (2010) 1.14
Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action. J Med Chem (2006) 1.03
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center. Res Microbiol (2003) 1.02
Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World J Gastroenterol (2008) 1.01
Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C. Emerg Infect Dis (2004) 1.01
Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibility. Inflamm Bowel Dis (2007) 1.01
Retracted The microbiota in inflammatory bowel disease in different age groups. Dig Dis (2009) 0.99
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2011) 0.99
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol (2010) 0.99
Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS One (2013) 0.99
GSH and analogs in antiviral therapy. Mol Aspects Med (2008) 0.98
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol (2011) 0.97
Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy. Am J Gastroenterol (2005) 0.96
Elevated levels of miR-145 correlate with SMAD3 down-regulation in cystic fibrosis patients. J Cyst Fibros (2013) 0.96
Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males. PLoS One (2012) 0.96
Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.95
New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy. Clin Dev Immunol (2013) 0.94
Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease. Inflamm Bowel Dis (2009) 0.94
Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr (2012) 0.94
Current status of MR imaging in the evaluation of IBD in a pediatric population of patients. Eur J Radiol (2009) 0.94
Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients. J Clin Microbiol (2010) 0.94
MR enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease. Eur Radiol (2010) 0.93
The molecular class C acid phosphatase of Chryseobacterium meningosepticum (OlpA) is a broad-spectrum nucleotidase with preferential activity on 5'-nucleotides. Biochim Biophys Acta (2003) 0.92
Histone-like proteins and the Shigella invasivity regulon. Res Microbiol (2002) 0.92
Intralesional steroid injection after endoscopic balloon dilation in pediatric Crohn's disease with stricture: a prospective, randomized, double-blind, controlled trial. Gastrointest Endosc (2010) 0.92
Retracted Gut microbiota and pediatric disease. Dig Dis (2011) 0.92
Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy. Antioxid Redox Signal (2011) 0.91
The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrument. Clin Gastroenterol Hepatol (2006) 0.91
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease. Infect Immun (2012) 0.90
Gluten-free sourdough wheat baked goods appear safe for young celiac patients: a pilot study. J Pediatr Gastroenterol Nutr (2010) 0.89
Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 0.89
Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes. Microbes Infect (2006) 0.89
Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem Cell Biol (2006) 0.89
Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.88
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease. Inflamm Bowel Dis (2014) 0.87
Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS. Cell Microbiol (2014) 0.87
Lactoferrin functions: current status and perspectives. J Clin Gastroenterol (2004) 0.87
Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol (2010) 0.86
Enteric neuropathology of congenital intestinal obstruction: A case report. World J Gastroenterol (2006) 0.86
Pepstatin A alters host cell autophagic machinery and leads to a decrease in influenza A virus production. J Cell Physiol (2011) 0.86
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial. Helicobacter (2004) 0.86
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease. Inflamm Bowel Dis (2012) 0.86
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features. BMC Res Notes (2014) 0.85
Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis (2013) 0.85
Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease. Inflamm Bowel Dis (2008) 0.85
Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis (2004) 0.85
Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities. J Med Chem (2008) 0.85
The Environmental Pollutant Cadmium Promotes Influenza Virus Replication in MDCK Cells by Altering Their Redox State. Int J Mol Sci (2013) 0.84
Analysis of candidate genes on chromosomes 5q and 19p in celiac disease. J Pediatr Gastroenterol Nutr (2007) 0.84
Enteroinvasive Escherichia coli virulence-plasmid-carried apyrase (apy) and ospB genes are organized as a bicistronic operon and are subject to differential expression. Microbiology (2002) 0.84
Usefulness of single-balloon enteroscopy in pediatric Crohn's disease. Gastrointest Endosc (2012) 0.84
A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease. Can J Microbiol (2012) 0.84
Tacrolimus and food allergy. Transplantation (2003) 0.84
Outer membrane protein A (OmpA): a new player in shigella flexneri protrusion formation and inter-cellular spreading. PLoS One (2012) 0.84
Chronic granulomatous disease mimicking early-onset Crohn's disease with cutaneous manifestations. BMC Pediatr (2014) 0.83
Detection of Crohn disease lesions of the small and large bowel in pediatric patients: diagnostic value of MR enterography versus reference examinations. AJR Am J Roentgenol (2014) 0.83
Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn's disease patients treated with infliximab. J Neurovirol (2011) 0.83
Efficacy of adalimumab in moderate-to-severe pediatric Crohn's disease. Am J Gastroenterol (2009) 0.83
Viral hemagglutinin is involved in promoting the internalisation of Staphylococcus aureus into human pneumocytes during influenza A H1N1 virus infection. Int J Med Microbiol (2011) 0.83
Biochemical characterization of the class B acid phosphatase (AphA) of Escherichia coli MG1655. Biochim Biophys Acta (2005) 0.83
Nitric oxide production in rectal dialysate is a marker of disease activity and location in children with inflammatory bowel disease. Am J Gastroenterol (2002) 0.83
Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases. Biometals (2014) 0.82
Allergic proctocolitis refractory to maternal hypoallergenic diet in exclusively breast-fed infants: a clinical observation. BMC Gastroenterol (2011) 0.82
Plasticity of the P junc promoter of ISEc11, a new insertion sequence of the IS1111 family. J Bacteriol (2006) 0.82
Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. J Med Microbiol (2004) 0.82
Role of gastroesophageal reflux in children with unexplained chronic cough. J Pediatr Gastroenterol Nutr (2011) 0.82
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release. World J Gastroenterol (2012) 0.82
Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease. Atherosclerosis (2007) 0.82